Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment

NeuroImage: Clinical

Volumn 20, Issue , 2018, Pages 286-296

  Weise, Christopher M ^a   Chen, Kewei ^b,e,g   Chen, Yinghua ^b,g   Kuang, Xiaoying ^b,g   Savage, Cary R ^b,f   Reiman, Eric M ^b,c,d,e,g  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b BANNER ALZHEIMER S INSTITUTE   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^g ARIZONA ALZHEIMER S CONSORTIUM   (United States)

Author keywords

Alzheimer's disease; FDG PET; Lateralization; MCI

Indexed keywords

AMYLOID BETA PROTEIN; FLORBETAPIR F 18; GLUCOSE; ANILINE DERIVATIVE; ETHYLENE GLYCOL DERIVATIVE; FLORBETAPIR;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CEREBROSPINAL FLUID ANALYSIS; CINGULATE GYRUS; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HEMISPHERIC DOMINANCE; HUMAN; INFERIOR TEMPORAL GYRUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MIDDLE TEMPORAL GYRUS; MILD COGNITIVE IMPAIRMENT; PARAHIPPOCAMPAL GYRUS; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PRIORITY JOURNAL; SUPERIOR PARIETAL LOBULE; BRAIN; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; METABOLISM; PROCEDURES; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; BRAIN; COGNITIVE DYSFUNCTION; ETHYLENE GLYCOLS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; LONGITUDINAL STUDIES; MALE; POSITRON-EMISSION TOMOGRAPHY;

EID: 85050873828     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2018.07.016     Document Type: Article

References (53)

1. Agcaoglu, O., Miller, R., Mayer, A.R., Hugdahl, K., Calhoun, V.D., Lateralization of resting state networks and relationship to age and gender. NeuroImage 104 (2015), 310–325, 10.1016/j.neuroimage.2014.09.001.
2. Berti, V., Mosconi, L., Pupi, A., Brain: Normal variations and benign findings in FDG PET/CT imaging. PET Clin. 9 (2014), 129–140, 10.1016/j.cpet.2013.10.006.
3. Buckner, R.L., Snyder, A.Z., Shannon, B.J., Larossa, G., Sachs, R., Fotenos, A.F., Sheline, Y.I., Klunk, W.E., Mathis, C.A., Morris, J.C., Mintun, M.A., Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25 (2005), 7709–7717, 10.1523/JNEUROSCI.2177-05.2005.
4. Claassen, D.O., McDonell, K.E., Donahue, M., Rawal, S., Wylie, S.A., Neimat, J.S., Kang, H., Hedera, P., Zald, D., Landman, B., Dawant, B., Rane, S., Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere. Brain Behav., 6, 2016, 10.1002/brb3.573.
5. De Winter, F.-L., Zhu, Q., Van den Stock, J., Nelissen, K., Peeters, R., de Gelder, B., Vanduffel, W., Vandenbulcke, M., Lateralization for dynamic facial expressions in human superior temporal sulcus. NeuroImage 106 (2015), 340–352, 10.1016/j.neuroimage.2014.11.020.
6. Derflinger, S., Sorg, C., Gaser, C., Myers, N., Arsic, M., Kurz, A., Zimmer, C., Wohlschläger, A., Mühlau, M., Grey-matter atrophy in Alzheimer's disease is asymmetric but not lateralized. J. Alzheimers Dis. 25 (2011), 347–357, 10.3233/JAD-2011-110041.
7. Folstein, M.F., Folstein, S.E., McHugh, P.R., “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975), 189–198.
8. Friedland, R.P., Budinger, T.F., Koss, E., Ober, B.A., Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci. Lett. 53 (1985), 235–240.
9. Galton, C.J., Patterson, K., Xuereb, J.H., Hodges, J.R., Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123 (2000), 484–498, 10.1093/brain/123.3.484.
10. Gorno-Tempini, M.L., Dronkers, N.F., Rankin, K.P., Ogar, J.M., Phengrasamy, L., Rosen, H.J., Johnson, J.K., Weiner, M.W., Miller, B.L., Cognition and anatomy in three variants of primary progressive aphasia. Ann. Neurol. 55 (2004), 335–346, 10.1002/ana.10825.
11. Greicius, M.D., Krasnow, B., Reiss, A.L., Menon, V., Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 253–258, 10.1073/pnas.0135058100.
12. Gutierrez-Sigut, E., Payne, H., MacSweeney, M., Investigating language lateralization during phonological and semantic fluency tasks using functional transcranial Doppler sonography. Laterality Asymmetries Body Brain Cogn. 20 (2015), 49–68, 10.1080/1357650X.2014.914950.
13. Haxby, J.V., Duara, R., Grady, C.L., Cutler, N.R., Rapoport, S.I., Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J. Cereb. Blood Flow Metab. 5 (1985), 193–200, 10.1038/jcbfm.1985.25.
14. Henry, M.L., Gorno-Tempini, M.L., The logopenic variant of primary progressive aphasia. Curr. Opin. Neurol. 23 (2010), 633–637, 10.1097/WCO.0b013e32833fb93e.
15. Herholz, K., Ebmeier, K., Clinical amyloid imaging in Alzheimer's disease. Lancet Neurol. 10 (2011), 667–670, 10.1016/S1474-4422(11)70123-5.
16. Ibáñez, V., Pietrini, P., Alexander, G.E., Furey, M.L., Teichberg, D., Rajapakse, J.C., Rapoport, S.I., Schapiro, M.B., Horwitz, B., Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50 (1998), 1585–1593, 10.1212/WNL.50.6.1585.
17. Jack, C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Petersen, R.C., Trojanowski, J.Q., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9 (2010), 119–128, 10.1016/S1474-4422(09)70299-6.
18. Jack, C.R., Albert, M.S., Knopman, D.S., McKhann, G.M., Sperling, R.A., Carrillo, M.C., Thies, B., Phelps, C.H., Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. J. Alzheimers Assoc. 7 (2011), 257–262, 10.1016/j.jalz.2011.03.004.
19. Jack, C.R., Bennett, D.A., Blennow, K., Carrillo, M.C., Dunn, B., Haeberlein, S.B., Holtzman, D.M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J.L., Montine, T., Phelps, C., Rankin, K.P., Rowe, C.C., Scheltens, P., Siemers, E., Snyder, H.M., Sperling, R., Elliott, C., Masliah, E., Ryan, L., Silverberg, N., NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. J. Alzheimers Assoc. 14 (2018), 535–562, 10.1016/j.jalz.2018.02.018.
20. Janke, A.L., de Zubicaray, G., Rose, S.E., Griffin, M., Chalk, J.B., Galloway, G.J., 4D deformation modeling of cortical disease progression in Alzheimer's dementia. Magn. Reson. Med. 46 (2001), 661–666.
21. Janota, I., Mountjoy, C.Q., Asymmetry of pathology in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 51 (1988), 1011–1012.
22. Jucker, M., Walker, L.C., Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501 (2013), 45–51, 10.1038/nature12481.
23. Keilp, J.G., Alexander, G.E., Stern, Y., Prohovnik, I., Inferior parietal perfusion, lateralization, and neuropsychological dysfunction in Alzheimer's disease. Brain Cogn. 32 (1996), 365–383, 10.1006/brcg.1996.0071.
24. Loewenstein, D.A., Barker, W.W., Chang, J.Y., Apicella, A., Yoshii, F., Kothari, P., Levin, B., Duara, R., Predominant left hemisphere metabolic dysfunction in dementia. Arch. Neurol. 46 (1989), 146–152.
25. Madhavan, A., Whitwell, J.L., Weigand, S.D., Duffy, J.R., Strand, E.A., Machulda, M.M., Tosakulwong, N., Senjem, M.L., Gunter, J.L., Lowe, V.J., Petersen, R.C., Jack, C.R., Josephs, K.A., FDG PET and MRI in Logopenic primary progressive aphasia versus dementia of the Alzheimer's type. PLoS One, 8, 2013, 10.1371/journal.pone.0062471.
26. Meinzer, M., Wilser, L., Flaisch, T., Eulitz, C., Rockstroh, B., Conway, T., Rothi, L.J.G., Crosson, B., Neural signatures of semantic and phonemic fluency in young and old adults. J. Cogn. Neurosci. 21 (2009), 2007–2018, 10.1162/jocn.2009.21219.
27. Mohs, R.C., Knopman, D., Petersen, R.C., Ferris, S.H., Ernesto, C., Grundman, M., Sano, M., Bieliauskas, L., Geldmacher, D., Clark, C., Thal, L.J., Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's disease assessment scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis. Assoc. Disord. 11:Suppl 2 (1997), S13–S21.
28. Morris, J.C., The clinical dementia rating (CDR): current version and scoring rules. Neurology 43 (1993), 2412–2414.
29. Mosconi, L., Glucose metabolism in normal aging and Alzheimer's disease: methodological and physiological considerations for PET studies. Clin. Transl. Imaging Rev. Nucl. Med. Mol. Imaging, 1, 2013, 10.1007/s40336-013-0026-y.
30. Ossenkoppele, R., Cohn-Sheehy, B.I., La Joie, R., Vogel, J.W., Möller, C., Lehmann, M., van Berckel, B.N.M., Seeley, W.W., Pijnenburg, Y.A., Gorno-Tempini, M.L., Kramer, J.H., Barkhof, F., Rosen, H.J., van der Flier, W.M., Jagust, W.J., Miller, B.L., Scheltens, P., Rabinovici, G.D., Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Hum. Brain Mapp. 36 (2015), 4421–4437, 10.1002/hbm.22927.
31. Palmqvist, S., Schöll, M., Strandberg, O., Mattsson, N., Stomrud, E., Zetterberg, H., Blennow, K., Landau, S., Jagust, W., Hansson, O., Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat. Commun., 8(1214), 2017, 10.1038/s41467-017-01150-x.
32. Perani, D., FDG-PET and amyloid-PET imaging: the diverging paths. Curr. Opin. Neurol. 27 (2014), 405–413, 10.1097/WCO.0000000000000109.
33. Petersen, R.C., Aisen, P.S., Beckett, L.A., Donohue, M.C., Gamst, A.C., Harvey, D.J., Jack, C.R., Jagust, W.J., Shaw, L.M., Toga, A.W., Trojanowski, J.Q., Weiner, M.W., Alzheimer's disease neuroimaging initiative (ADNI): clinical characterization. Neurology 74 (2010), 201–209, 10.1212/WNL.0b013e3181cb3e25.
34. Pievani, M., Pini, L., Ferrari, C., Pizzini, F.B., Boscolo Galazzo, I., Cobelli, C., Cotelli, M., Manenti, R., Frisoni, G.B., Coordinate-based meta-analysis of the default mode and salience network for target identification in non-invasive brain stimulation of Alzheimer's disease and behavioral variant frontotemporal dementia networks. J. Alzheimers Dis. 57 (2017), 825–843, 10.3233/JAD-161105.
35. Raji, C.A., Becker, J.T., Tsopelas, N.D., Price, J.C., Mathis, C.A., Saxton, J.A., Lopresti, B.J., Hoge, J.A., Ziolko, S.K., Dekosky, S.T., Klunk, W.E., Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh compound B. J. Neurosci. Methods 172 (2008), 277–282, 10.1016/j.jneumeth.2008.05.005.
36. Reiman, E.M., Jagust, W.J., Brain imaging in the study of Alzheimer's disease. NeuroImage 61 (2012), 505–516, 10.1016/j.neuroimage.2011.11.075.
37. Rey, A., L'examen Clinique en Psychologie. 1964, Presses Universitaires de France, Paris.
38. Rohrer, J.D., Rossor, M.N., Warren, J.D., Alzheimer's pathology in primary progressive aphasia. Neurobiol. Aging 33 (2012), 744–752, 10.1016/j.neurobiolaging.2010.05.020.
39. Rosen, W.G., Verbal fluency in aging and dementia. J. Clin. Neuropsychol. 2 (1980), 135–146, 10.1080/01688638008403788.
40. Rosen, W.G., Mohs, R.C., Davis, K.L., A new rating scale for Alzheimer's disease. Am. J. Psychiatry 141 (1984), 1356–1364, 10.1176/ajp.141.11.1356.
41. Saint-Aubert, L., Lemoine, L., Chiotis, K., Leuzy, A., Rodriguez-Vieitez, E., Nordberg, A., Tau PET imaging: present and future directions. Mol. Neurodegener., 12, 2017, 10.1186/s13024-017-0162-3.
42. Shi, F., Liu, B., Zhou, Y., Yu, C., Jiang, T., Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: meta-analyses of MRI studies. Hippocampus 19 (2009), 1055–1064, 10.1002/hipo.20573.
43. Siegel, B.V., Shihabuddin, L., Buchsbaum, M.S., Starr, A., Haier, R.J., Valladares Neto, D.C., Gender differences in cortical glucose metabolism in Alzheimer's disease and normal aging. J. Neuropsychiatry Clin. Neurosci. 8 (1996), 211–214, 10.1176/jnp.8.2.211.
44. Small, G.W., Mazziotta, J.C., Collins, M.T., Baxter, L.R., Phelps, M.E., Mandelkern, M.A., Kaplan, A., La Rue, A., Adamson, C.F., Chang, L., Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273 (1995), 942–947.
45. Swanson, N., Eichele, T., Pearlson, G., Kiehl, K., Yu, Q., Calhoun, V.D., Lateral differences in the default mode network in healthy controls and schizophrenia patients. Hum. Brain Mapp. 32 (2011), 654–664, 10.1002/hbm.21055.
46. Thompson, P.M., Moussai, J., Zohoori, S., Goldkorn, A., Khan, A.A., Mega, M.S., Small, G.W., Cummings, J.L., Toga, A.W., Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb. Cortex 8 (1998), 492–509, 10.1093/cercor/8.6.492.
47. Thompson, P.M., Mega, M.S., Woods, R.P., Zoumalan, C.I., Lindshield, C.J., Blanton, R.E., Moussai, J., Holmes, C.J., Cummings, J.L., Toga, A.W., Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb. Cortex N. Y. N 1991:11 (2001), 1–16.
48. Volkow, N.D., Zhu, W., Felder, C.A., Mueller, K., Welsh, T.F., Wang, G.J., de Leon, M.J., Changes in brain functional homogeneity in subjects with Alzheimer's disease. Psychiatry Res. 114 (2002), 39–50.
49. Walker, L.C., Diamond, M.I., Duff, K.E., Hyman, B.T., Mechanisms of protein seeding in neurodegenerative diseases. JAMA Neurol. 70 (2013), 304–310, 10.1001/jamaneurol.2013.1453.
50. Wilcock, G.K., Esiri, M.M., Asymmetry of pathology in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 50 (1987), 1384–1386.
51. Wilke, M., Lidzba, K., LI-tool: a new toolbox to assess lateralization in functional MR-data. J. Neurosci. Methods 163 (2007), 128–136, 10.1016/j.jneumeth.2007.01.026.
52. Yeung, M.K., Sze, S.L., Woo, J., Kwok, T., Shum, D.H.K., Yu, R., Chan, A.S., Altered frontal lateralization underlies the category fluency deficits in older adults with mild cognitive impairment: a near-infrared spectroscopy study. Front. Aging Neurosci., 8, 2016, 10.3389/fnagi.2016.00059.
53. Zahn, R., Juengling, F., Bubrowski, P., Jost, E., Dykierek, P., Talazko, J., Huell, M., Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res. Neuroimaging 132 (2004), 159–172, 10.1016/j.pscychresns.2004.07.006.